Skip to content

Targeted NGS Empowers Genetic Testing

The Illumina Genomics Podcast

Targeted NGS Empowers Genetic Testing

Nov 03, 2017 | Episode 11 | 16 mins

According to the US National Library of Medicine's Genetic Testing Registry, 10,000 conditions can be identified with genetic testing. The high-throughput and relatively low cost of NGS is advantageous for multigene testing. Dr. Samuel Myllykangas, co-founder of Blueprint Genetics, discusses how current and future NGS innovations may impact genetic testing.

Download or subscribe to our recurring podcasts.